A diff?rents temps, la souris sera anesth?si?e et passera sous le Nanospect ,
Les images du Nanospect/CT et du Micro-PET sont acquises?1acquises?acquises?1 heure post-injection. Puis dans un second temps, nous injectons du 89 Zr-Df-Bz-NCS-Rituximab [100&l ; 1,2 MBq] par la veine caudale, Les images du Nanospect/CT et du Micro-PET sont acquises?24acquises?acquises?24, 48 et 72 heures post-injection afin dÕobserver la fixation de notre produit ,
On Some Morbid Appearances of the Absorbent Glands and Spleen, Journal of the Royal Society of Medicine, vol.17, issue.1, pp.68-114, 1832. ,
DOI : 10.1177/095952873201700106
Neue Notiz Gebiete Natur-und Heilkunde, pp.151-156, 1845. ,
?ber eine eigenartige unter dem Bilde der Pseudoleuk?mie verlaufende Tuberkulose des lymphatischen Apparates. Zeitschrift Fur Heilkunde, pp.21-90, 1898. ,
On the pathological changes in Hodgkin's disease, with especial reference to its relation to tuberculosis, Johns Hopkins Hospital Reports, vol.10, pp.133-196, 1902. ,
GENERALIZED GIANT LYMPH FOLLICLE HYPERPLASIA OF LYMPH NODES AND SPLEEN, Journal of the American Medical Association, vol.84, issue.9, pp.668-671, 1925. ,
DOI : 10.1001/jama.1925.02660350032008
??tude historique des lymphomes et de leurs classifications, Revue Francophone des Laboratoires, vol.2014, issue.458, pp.59-65, 2014. ,
DOI : 10.1016/S1773-035X(14)72316-0
The Histopathology of Malignant Lymphoma, British Journal of Haematology, vol.71, issue.s1, pp.193-203, 1975. ,
DOI : 10.1016/S0140-6736(72)92215-5
Immunologic characterization of human malignant lymphomas, Cancer, vol.58, issue.S8 ,
DOI : 10.1002/1097-0142(197410)34:8+<1488::AID-CNCR2820340822>3.0.CO;2-C
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma study group, Current Diagnostic Pathology, vol.2, issue.1, pp.1361-1392, 1994. ,
DOI : 10.1016/S0968-6053(00)80051-4
WHO classification of tumours of haematopoietic and lymphoid tissues, 2008. ,
Les lymphomes malins, hodgkiniens et non hodgkiniens, 2011. ,
Estimations nationale de lÕincidence des cancers en France entre, Septembre 2013, Partie 2 Ð h?mopathies malignes, pp.28-31, 1980. ,
Lymphomes B inclassables avec des caract?ristiques interm?diaires entre lelymphome B diffus?grandesdiffus?diffus?grandes cellules et le lymphome de Burkitt : Evaluation r?trospective des caract?ristiques cliniques et impact de l'intensification th?rapeutique, 2013. ,
The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research, British Journal of Haematology, vol.100, issue.5, pp.739-753, 2010. ,
DOI : 10.1111/j.1365-2141.2009.08010.x
Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab, Journal of Clinical Oncology, vol.28, issue.20 ,
DOI : 10.1200/JCO.2009.26.3947
Distinct types of diffuse large B-cell lymphoma identified by gene expression
profiling, Nature, vol.303, issue.6769, pp.503-511, 2000. ,
DOI : 10.1038/35000501
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma, New England Journal of Medicine, vol.346, issue.25, 2002. ,
DOI : 10.1056/NEJMoa012914
Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma, Blood, vol.106, issue.5, p.3052, 2005. ,
DOI : 10.1182/blood-2005-02-0542
Stromal Gene Signatures in Large-B-Cell Lymphomas, New England Journal of Medicine, vol.359, issue.22 ,
DOI : 10.1056/NEJMoa0802885
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray, Blood, vol.103, issue.1, pp.275-282, 2004. ,
DOI : 10.1182/blood-2003-05-1545
Constitutive Nuclear Factor ??B Activity Is Required for Survival of Activated B Cell???like Diffuse Large B Cell Lymphoma Cells, The Journal of Experimental Medicine, vol.15, issue.12, pp.1861-1874, 2001. ,
DOI : 10.1016/S0960-894X(98)00029-8
Structure, regulation and function of NF-kB ,
Phosphorylation Meets Ubiquitination: The Control of NF-??B Activity, Annual Review of Immunology, vol.18, issue.1, pp.621-663, 2000. ,
DOI : 10.1146/annurev.immunol.18.1.621
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-??B, Journal of Clinical Investigation, vol.107, issue.3, pp.241-246, 2001. ,
DOI : 10.1172/JCI11991
The molecular architecture of the TNF superfamily, Trends in Biochemical Sciences, vol.27, issue.1, pp.19-26, 2002. ,
DOI : 10.1016/S0968-0004(01)01995-8
Recent trends in antibody-based oncologic imaging, Cancer Letters, vol.315, issue.2, pp.97-111, 2012. ,
DOI : 10.1016/j.canlet.2011.10.017
Th?se de physique : Imagerie par rayonnement gamma diffus??hautediffus??diffus??haute sensibilit?, 2008. ,
PET versus SPECT: strengths, limitations and challenges, Nuclear Medicine Communications, vol.29, issue.3, pp.193-207, 2008. ,
DOI : 10.1097/MNM.0b013e3282f3a515
Radiopharmaceutiques-Chimie des radiotraceurs et applications biologiques, pp.350-64, 1998. ,
Electrophilic substitution dans : Radioiodination reactions for pharmaeuticals, pp.45-62, 2006. ,
TEMP : les possibilit?s de marquagê lÕiode 123 ou au techn?tium. M?decine Nucl?aire -Imagerie fonctionnelle et m?tabolique, pp.29-33, 2005. ,
Radiohalogenation of proteins: An overview of radionuclides, labeling methods and reagents for conjugate labeling, Bioconjugate Chemistry, vol.3, issue.6, pp.433-470, 1992. ,
DOI : 10.1021/bc00018a001
68Ga-labelled recombinant antibody variants for immuno-PET imaging of solid tumours, European Journal of Nuclear Medicine and Molecular Imaging, vol.66, issue.Suppl 1, pp.1397-1407, 2010. ,
DOI : 10.1007/s00259-010-1392-6
64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer, Journal of Nuclear Medicine, vol.54, issue.11, pp.1869-1875, 2013. ,
DOI : 10.2967/jnumed.112.118612
Ueber das zustandekommen der Diphterie-Immunit?t und der Tetanus-Immunit?t bei Thieren, Deutsch Medizinische Wochenschrift, vol.16, pp.1113-1114, 1890. ,
The formation of a specific inhibitor by hydrolysis of rabbit antiovalbumin, Biochemical Journal, vol.46, issue.4, pp.479-484, 1950. ,
DOI : 10.1042/bj0460479
Antibody production in relation to the development of plasma cells, Acta Medica Scandinavica, vol.204, 1948. ,
The immunologic reactivity of bovine serum albumin labeled with trace-amounts of radioactive iodine (I-131), The Journal of Immunology, vol.63, pp.71-80, 1950. ,
The in vivo localization of anti-Wagner-osteogenic-sarcoma antibodies, Cancer, vol.5, issue.3, pp.619-623, 1953. ,
DOI : 10.1002/1097-0142(195305)6:3<619::AID-CNCR2820060319>3.0.CO;2-Y
Immunological specificity of human insulin : Application to immunoassay of insulin, The Journal of Clinical Investigation, vol.40, pp.2190-2198, 1961. ,
Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, vol.3, issue.5517, pp.495-497, 1975. ,
DOI : 10.1038/256495a0
Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma, Cancer Research, vol.43, pp.5593-5600, 1983. ,
Use of Radio-Labeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning. The New England Jounal of Medicine, pp.1384-1388, 1978. ,
The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development, Clinical Cancer Research, vol.11, issue.22, pp.7967-7985, 2005. ,
DOI : 10.1158/1078-0432.CCR-05-1302
Antibody fragments: Prolonging circulation half-life special issue-antibody research, Advances in Bioscience and Biotechnology, vol.04, issue.05, 2013. ,
DOI : 10.4236/abb.2013.45090
URL : http://doi.org/10.4236/abb.2013.45090
Nouveau biomarqueur en temps r?el de cassures double-brin de lÕADN et g?notoxicit? de la Cytolethal Distending Toxin, Th?se Biologie Cellulaire, 2012. ,
The promise of immuno-PET in radioimmunotherapy, Journal of Nuclear Medicine, vol.46, pp.164-171, 2005. ,
Radiation Dosimetry of 89Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients, Journal of Nuclear Medicine, vol.50, issue.11, pp.1828-1836, 2009. ,
DOI : 10.2967/jnumed.109.065862
Performance of Immuno-Positron Emission Tomography with Zirconium-89-Labeled Chimeric Monoclonal Antibody U36 in the Detection of Lymph Node Metastases in Head and Neck Cancer Patients, Clinical Cancer Research, vol.12, issue.7, pp.2133-2140, 2006. ,
DOI : 10.1158/1078-0432.CCR-05-2137
89 Zr immuno-PET: comprehensive procedures for the production of 89 Zr-labeled monoclonal antibodies, Journal of Nuclear Medicine, issue.8, pp.441271-1281, 2003. ,
Quantitative ImmunoPET of Prostate Cancer Xenografts with 89Zr- and 124I-Labeled Anti-PSCA A11 Minibody, Journal of Nuclear Medicine, vol.55, issue.3, pp.452-459, 2014. ,
DOI : 10.2967/jnumed.113.120873
89 Zr-Immuno-PET : Physical Properties, Production, Labeling and Applications of 89 Zr, 2012. ,
In vivo imaging of the human thyroid with a positron camera using 1-124, European Journal of Nuclear Medicine, vol.10, pp.472-476, 1985. ,
89Zr, a Radiometal Nuclide with High Potential for Molecular Imaging with PET: Chemistry, Applications and Remaining Challenges, Molecules, vol.18, issue.6, pp.6469-6490, 2013. ,
DOI : 10.3390/molecules18066469
Factsheet, iodine 124 ,
Standardized methods for the production of high specific-activity zirconium-89, Nuclear Medicine and Biology, vol.36, issue.7, pp.729-739, 2009. ,
DOI : 10.1016/j.nucmedbio.2009.05.007
Overview of radionuclides useful for radioimmunoimaging and radioimmunotherapy and current status of preparing radiolabelled antibodies ,
Advances in ImmunoÐPositron Emission Tomography ,
Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer, Clinical Pharmacology & Therapeutics, vol.87, issue.5, pp.586-592, 2010. ,
DOI : 10.1162/153535003322556877
Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging, Journal of Nuclear Medicine, vol.50, issue.6, pp.974-981, 2009. ,
DOI : 10.2967/jnumed.108.060392
89 Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals 90 Y and 177 Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab, Journal of Nuclear Medicine, vol.46, pp.1898-1906, 2005. ,
The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games, Immunology, vol.163, issue.1, pp.1-20, 2005. ,
DOI : 10.1002/art.10968
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease, Nature, vol.404, issue.6781, pp.995-999, 2000. ,
DOI : 10.1038/35010115
Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy, European Journal of Haematology, vol.91, issue.3 ,
DOI : 10.1111/j.1600-0609.2008.01099.x
Signal Transduction, Correspondances en Onco-Hematologie, vol.32, pp.4-2011 ,
DOI : 10.1002/0471141755.ph0200s56
89 Zr for antibody labeling and positron emission tomography, Journal of Labelled Compounds and Radiopharmaceuticals, vol.23, pp.1297-1298, 1986. ,
Radiochemical synthesis of 89 Zr-porphyrin for positron label of monoclonal antibodies, Journal of Labelled Compounds and Radiopharmaceuticals, vol.30, p.326, 1991. ,
Evaluation of desferal as a bifunctional chelating agent for labeling antibodies with Zr-89, International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, vol.43, issue.12, pp.1443-1447, 1992. ,
DOI : 10.1016/0883-2889(92)90170-J
A facile method for the labeling of proteins with zirconium isotopes, Nuclear Medicine and Biology, vol.23, issue.4, pp.439-448, 1996. ,
DOI : 10.1016/0969-8051(96)00020-0
Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude mice, Journal of Nuclear Medicine, vol.38, pp.112-118, 1997. ,
p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging, European Journal of Nuclear Medicine and Molecular Imaging, vol.37, issue.2, pp.250-259, 2010. ,
DOI : 10.1007/s00259-009-1263-1
Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate pisothiocyanatobenzyldesferrioxamine, Nature Protocols, vol.5, p.4, 2010. ,
Development of a Novel Long-Lived ImmunoPET Tracer for Monitoring Lymphoma Therap in a Humanized Transgenic Mouse Model ,
Quantification de prot?ines. www.labome.fr/method ,
Transfer of proteins from gels to diazobenzyloxymethylpaper and detection with antisera: a method for studying antibody specificity and antigen structure, Proceedings of the National Academy of Sciences, pp.3116-3120, 1979. ,
Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess, Journal of Immunological Methods, vol.72, issue.1, pp.77-89, 1984. ,
DOI : 10.1016/0022-1759(84)90435-6
Immuno-PET imaging with 89Zr-rituximab in CD20+ B-cell lymphoma. Jules Bordet Cancer Institute, 2011. ,